The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.

BACKGROUND: Rates of non-medical use of opioids, and opioid use disorders (OUD) have been rising throughout North America. Methadone and buprenorphine/naloxone are the recommended first-line treatment options for OUD in Canada. Most studies to date have been conducted among heroin users, in controll...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Contemp Clin Trials
Hlavní autoři: SOCIAS, M. Eugenia, AHAMAD, Keith, LE FOLL, Bernard, LIM, Ron, BRUNEAU, Julie, FISCHER, Benedikt, WILD, T. Cameron, WOOD, Evan, JUTRAS-ASWAD, Didier
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6625801/
https://ncbi.nlm.nih.gov/pubmed/29627621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2018.04.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky